Prostate Cancer
Conditions
Brief summary
The overarching goal of this trial is to develop mechanisms to improve cardiovascular care among such prostate cancer patients receiving ADT by increasing patient awareness of individualized cardiovascular risk estimates and mitigation opportunities. Patients will be given access to a web-based quality improvement tool to educate patients of cardiovascular risks in prostate cancer and to inform them of their individualized, estimated cardiovascular risk and guideline-based risk mitigation recommendations. The study will assess the feasibility of this web-based application as a cardiovascular education tool for patients with prostate cancer. The study will also evaluate if completion of the web-based tool improves cardiovascular care access and risk mitigation for patients with prostate cancer.
Interventions
BEHAVIORALCARE-PC Web-Based Application
The CARE-PC app is a pragmatic, patient-oriented, web-based application that enables the education of patients regarding cardiovascular (CV) risks and collects CV and prostate cancer-related risk variables and CV care access data from prostate cancer patients receiving ADT.
Sponsors
National Comprehensive Cancer Network
Vivek Narayan
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Men with prostate cancer \> 18 years of age who are currently receiving or will be receiving treatment with ≥ 6 months of ADT * Patients must be able to read and understand English.
Exclusion criteria
n/a
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| CARE-PC Web-Based Application Completion Rate | 18 months | Completion rate measured as the proportion of participants successfully completing the web-based application out of the total number of subjects approached. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percent accuracy of patient-derived CV- and prostate cancer-related data elements | 18 months | Accuracy assessed through parallel medical chart review by cardiology and oncology clinicians |
| Prevalence of CV risk factors/disease at the time of CARE-PC web-based application participation | 18 months | Prevalence assessed through parallel medical chart review by cardiology and oncology clinicians |
| Patient acceptance and perception of the web-based application | 18 months | Acceptance/perception measured by brief embedded survey following participation in the web-based application |
| Proportion of participants engaging in CV care within 6 months of CARE-PC web application participation | 18 months | CV care engagement assessed through medical chart review by investigators within 6 months post-application survey completion |
| Proportion of participants having changes in CV risk-reducing medications within 6 months of CARE-PC application participation. | 18 months | Proportion of participants having changes in CV risk-reducing medications assessed through parallel medical chart review by cardiology and oncology clinicians within 6 months post-application survey completion |
| Proportion of participants with current cardiologist involvement in CV care at the time of web-based application participation | 18 months | Patient reported cardiologist involvement via CARE-PC application at time of application survey completion |
Countries
United States
Contacts
Primary ContactMatthew Doyle
Outcome results
None listed